Tiziana Life Sciences Announces IND filed for Phase 2 Study of Milciclib in Combination with Gemcitabine for Non-Small Cell Lung Cancer
Stock Information for Tiziana Life Sciences Ltd
Loading
Please wait while we load your information from QuoteMedia.